These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30760354)

  • 21. Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction.
    Garwood ER; Fidelman N; Hoch SE; Kerlan RK; Yao FY
    Liver Transpl; 2013 Feb; 19(2):164-73. PubMed ID: 23008091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer cells ablation with irreversible electroporation.
    Miller L; Leor J; Rubinsky B
    Technol Cancer Res Treat; 2005 Dec; 4(6):699-705. PubMed ID: 16292891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse effects of irreversible electroporation of malignant liver tumors under CT fluoroscopic guidance: a single-center experience.
    Dollinger M; Beyer LP; Haimerl M; Niessen C; Jung EM; Zeman F; Stroszczynski C; Wiggermann P
    Diagn Interv Radiol; 2015; 21(6):471-5. PubMed ID: 26359870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators.
    Bhattacharjya S; Bhattacharjya T; Quaglia A; Dhillon AP; Burroughs AK; Patch DW; Tibballs JM; Watkinson AF; Rolles K; Davidson BR
    Dig Surg; 2004; 21(2):152-9; discussion 159-60. PubMed ID: 15166485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pain analysis in patients with hepatocellular carcinoma: irreversible electroporation versus radiofrequency ablation-initial observations.
    Narayanan G; Froud T; Lo K; Barbery KJ; Perez-Rojas E; Yrizarry J
    Cardiovasc Intervent Radiol; 2013 Feb; 36(1):176-82. PubMed ID: 22752100
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.
    O'Connor JK; Trotter J; Davis GL; Dempster J; Klintmalm GB; Goldstein RM
    Liver Transpl; 2012 Aug; 18(8):949-54. PubMed ID: 22467602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of Occlusion of Hepatic Blood Vessels after Irreversible Electroporation of Liver Tumors.
    Tamura M; Pedersoli F; Schulze-Hagen M; Zimmerman M; Isfort P; Kuhl CK; Schmitz-Rode T; Bruners P
    J Vasc Interv Radiol; 2020 Dec; 31(12):2033-2042.e1. PubMed ID: 33267950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Irreversible electroporation for the ablation of liver tumors: are we there yet?
    Charpentier KP
    Arch Surg; 2012 Nov; 147(11):1053-61. PubMed ID: 23165618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unusual Techniques for Preserving Surgical and Oncologic Safety in Hepatectomy of Advanced Adrenal Malignancy with Vena Cava and Liver Invasion.
    Lee JM; Lee KW; Hong SK; Yoon KC; Cho JH; Yi NJ; Suh KS
    Ann Surg Oncol; 2018 Oct; 25(11):3324-3325. PubMed ID: 30019302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment outcomes of transcatheter arterial chemoembolization for hepatocellular carcinoma that invades hepatic vein or inferior vena cava.
    Chung SM; Yoon CJ; Lee SS; Hong S; Chung JW; Yang SW; Seong NJ; Jang ES; Kim JW; Jeong SH
    Cardiovasc Intervent Radiol; 2014 Dec; 37(6):1507-15. PubMed ID: 24464259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: a prospective single-center study.
    Niessen C; Igl J; Pregler B; Beyer L; Noeva E; Dollinger M; Schreyer AG; Jung EM; Stroszczynski C; Wiggermann P
    J Vasc Interv Radiol; 2015 May; 26(5):694-702. PubMed ID: 25812712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous ablation therapy of hepatocellular carcinoma with irreversible electroporation: MRI findings.
    Granata V; Fusco R; Catalano O; Piccirillo M; De Bellis M; Izzo F; Petrillo A
    AJR Am J Roentgenol; 2015 May; 204(5):1000-7. PubMed ID: 25905934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultrasound-guided percutaneous irreversible electroporation of hepatic and abdominal tumors not eligible for surgery or thermal ablation: a western report on safety and efficacy.
    Giorgio A; Amendola F; Calvanese A; Ingenito E; Santoro B; Gatti P; Ciracì E; Matteucci P; Giorgio V
    J Ultrasound; 2019 Mar; 22(1):53-58. PubMed ID: 30843171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical application of LDLT after reconstruction of IVC using artificial blood vessel in the treatment of HCC beyond Milan Criteria].
    Sun BC; Li GQ; Huang XL; Qin JJ; Mu XX
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):211-215. PubMed ID: 29575841
    [No Abstract]   [Full Text] [Related]  

  • 36. Irreversible electroporation of hepatocellular carcinoma and colorectal cancer liver metastases: A nationwide multicenter study with short- and long-term follow-up.
    Frühling P; Stillström D; Holmquist F; Nilsson A; Freedman J
    Eur J Surg Oncol; 2023 Nov; 49(11):107046. PubMed ID: 37716017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Irreversible Electroporation as a Valid Treatment Option for Hepatic Epithelioid Hemangioendothelioma: An International Multicenter Experience.
    Narayanan G; Spano A; Gentile NT; Shnayder-Adams MM; Gurusamy V; Levi DM; Wilky BA; Mora RA; Noman R; Peddu P; Dijkstra M
    Cardiovasc Intervent Radiol; 2024 Jul; 47(7):883-890. PubMed ID: 38844684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-Eluting Bead Transarterial Chemoembolization as Bridge Therapy for Hepatocellular Carcinoma Before Living-Donor Liver Transplantation.
    Yu CY; Ou HY; Weng CC; Huang TL; Chen TY; Leung-Chit L; Hsu HW; Chen CL; Cheng YF
    Transplant Proc; 2016 May; 48(4):1045-8. PubMed ID: 27320552
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aggressive combined resection of hepatic inferior vena cava, with replacement by a ringed expanded polytetrafluoroethylene graft, in living-donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Matsuda H; Sadamori H; Shinoura S; Umeda Y; Yoshida R; Satoh D; Utsumi M; Onishi T; Yagi T
    J Hepatobiliary Pancreat Sci; 2010 Sep; 17(5):719-24. PubMed ID: 20425126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a robotic system for irreversible electroporation (IRE) of malignant liver tumors: initial results.
    Beyer LP; Pregler B; Michalik K; Niessen C; Dollinger M; Müller M; Schlitt HJ; Stroszczynski C; Wiggermann P
    Int J Comput Assist Radiol Surg; 2017 May; 12(5):803-809. PubMed ID: 27653615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.